悦心健康(002162) - 2018 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2018 was ¥145,774,417.64, a decrease of 0.55% compared to ¥146,580,230.80 in the same period last year[7] - The net profit attributable to shareholders was a loss of ¥12,049,923.61, representing an increase in loss of 11.31% from a loss of ¥10,825,583.04 in the previous year[7] - The net cash flow from operating activities was negative at ¥21,282,637.90, a significant decline of 241.48% compared to a positive cash flow of ¥15,042,456.44 in the same period last year[7] - The weighted average return on net assets was -1.39%, a decrease of 0.09% compared to -1.29% in the previous year[7] - Investment income decreased by 48.23% year-on-year to 618,105.25, primarily due to a decline in performance from Xingshan Insurance Agency[20] - The expected net profit attributable to shareholders for the first half of 2018 is projected to range from 500 to 1,500 million, reflecting a change of -59.00% to 22.00% compared to 1,225.23 million in the same period of 2017[30] Assets and Liabilities - The total assets at the end of the reporting period were ¥2,116,463,259.36, showing a slight increase of 0.06% from ¥2,115,181,556.57 at the end of the previous year[7] - The net assets attributable to shareholders decreased by 1.33% to ¥863,631,176.22 from ¥875,313,611.32 at the end of the previous year[7] - The company reported a significant increase of 80.21% in prepaid expenses, amounting to ¥19,336,449.84 compared to ¥10,730,234.81 at the end of the previous year[16] - The company’s employee compensation payable decreased by 46.32% to ¥11,370,064.58 from ¥21,179,341.12 at the end of the previous year[16] Cash Flow - Net cash flow from operating activities for Q1 2018 was -21,282,637.90, a decrease of 241.48% compared to 15,042,456.44 in Q1 2017[23] - The net cash flow from financing activities decreased by 68.17% to 10,091,196.81, compared to 31,700,490.84 in the previous year[23] Shareholder Information - The top shareholder, CIMIC Industrial Inc., holds 46.73% of the shares, with 399,795,802 shares pledged[11] - The company reported a significant decrease in minority shareholder losses, with a loss of -998,056.84 in Q1 2018, compared to -357,026.65 in Q1 2017, marking a 179.55% increase in losses[21] Regulatory and Compliance - The company received conditional approval from the China Securities Regulatory Commission for its asset acquisition and fundraising plan on January 17, 2018[26] - The company has not reported any overdue commitments from actual controllers, shareholders, or related parties during the reporting period[29] - There were no violations regarding external guarantees during the reporting period[32] - The company did not report any non-recurring gains or losses that were classified as recurring during the reporting period[9] Future Plans - The company plans to acquire 100% equity of multiple hospitals through a share issuance, with a total fundraising amount not exceeding 36,983.86 million[24] Other Income - Other income for Q1 2018 was 221,891.01, a significant increase compared to the previous year, which had no recorded amount[19]